EP Patent

EP1140192A2 — Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia

Assigned to GD Searle LLC · Expires 2001-10-10 · 25y expired

What this patent protects

The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of a cyclooxygenase-2 inhibitor and an antineoplastic agent.

USPTO Abstract

The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of a cyclooxygenase-2 inhibitor and an antineoplastic agent.

Drugs covered by this patent

Patent Metadata

Patent number: EP1140192A2
Jurisdiction: EP
Classification: —
Expires: 2001-10-10
Drug substance claim: No
Drug product claim: No
Assignee: GD Searle LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.